UBS Declares Quarterly Coupon Payments on Exchange Traded Notes: AMU and AMUB

NEW YORK–(BUSINESS WIRE)–UBS Investment Bank today announced coupon payments for the ETRACS
Alerian MLP Index ETN
(NYSE Arca: “AMU”) and ETRACS
Alerian MLP Index ETN Series B
(NYSE Arca: “AMUB”), both traded on
the NYSE Arca.

NYSE
Ticker

 

ETN Name and Prospectus/
Pricing Supplement*

 

Valuation
Date

 

Ex-
Date

 

Record
Date

 

Payment
Date

 

Coupon
Amount

 

Payment
Schedule

 

Current Yield
(annualized)**

AMU  

ETRACS
Alerian MLP Index ETN

  5/15/19   5/28/19   5/29/19   6/6/19   $0.2609   Quarterly   6.45%
AMUB  

ETRACS
Alerian MLP Index ETN Series B

  5/15/19   5/28/19   5/29/19   6/6/19   $0.2609   Quarterly   6.45%

* The table above provides a hyperlink to the relevant prospectus and
supplements thereto for each of our ETRACS ETNs, which are identified by
their names. For more information on each ETRACS ETN, see “List
of ETNs
“.

**”Current Yield (annualized)” equals the current Coupon Amount,
multiplied by four (to annualize such coupon), divided by the Closing
Indicative Value of the ETN on its current Coupon Valuation Date rounded
to two decimal places for ease of analysis. The Current Yield is not
indicative of future coupon payments, if any, on the ETN. You are not
guaranteed any coupon or distribution amount under the ETN.

About ETRACS

ETRACS ETNs are senior unsecured notes issued by UBS AG, are traded on
NYSE Arca, and can be bought and sold through a broker or financial
advisor. An investment in ETRACS ETNs is subject to a number of
risks, including the risk of loss of some or all of the investor’s
principal, and is subject to the creditworthiness of UBS AG. Investors
are not guaranteed any coupon or distribution amount under the
ETNs.
We urge you to read the more detailed explanation of risks described
under “Risk Factors” in the applicable prospectus supplement, or product
supplement and pricing supplement, as applicable, for the ETRACS ETN.

UBS AG has filed a registration statement (including a prospectus and
supplements thereto) with the Securities and Exchange Commission, or
SEC, for the offerings of securities to which this communication
relates. Before you invest, you should read the prospectus, along with
the applicable prospectus, pricing, or product supplement to understand
fully the terms of the securities and other considerations that are
important in making a decision about investing in the ETRACS. The
applicable offering document for each ETRACS may be obtained by clicking
on the name of each ETRACS identified above. You may also get these
documents without cost by visiting EDGAR on the SEC website at www.sec.gov.
The securities related to the offerings are not deposit liabilities and
are not insured or guaranteed by the Federal Deposit Insurance
Corporation or any other governmental agency of the United States,
Switzerland or any other jurisdiction.

About UBS

UBS provides financial advice and solutions to wealthy, institutional
and corporate clients worldwide, as well as private clients in
Switzerland. UBS’ strategy is centered on our leading global wealth
management business and our premier universal bank in Switzerland,
enhanced by Asset Management and the Investment Bank. The bank focuses
on businesses that have a strong competitive position in their targeted
markets, are capital efficient, and have an attractive long-term
structural growth or profitability outlook.

UBS is present in all major financial centers worldwide. It has offices
in 52 countries, with about 34% of its employees working in the
Americas, 34% in Switzerland, 18% in the rest of Europe, the Middle East
and Africa and 14% in Asia Pacific. UBS Group AG employs approximately
61,000 people around the world. Its shares are listed on the SIX Swiss
Exchange and the New York Stock Exchange (NYSE).

This material is issued by UBS AG and/or any of its subsidiaries and/or
any of its affiliates (“UBS”). Products and services mentioned in this
material may not be available for residents of certain jurisdictions.
Past performance is not necessarily indicative of future results. Please
consult the restrictions relating to the product or service in question
for further information. Activities with respect to US securities are
conducted through UBS Securities LLC, a US broker/dealer. Member of SIPC
(http://www.sipc.org/).

ETRACS ETNs are sold only in conjunction with the relevant offering
materials. UBS has filed a registration statement (including a
prospectus, as supplemented by the applicable prospectus supplement, or
product supplement and pricing supplement, for the offering of the
ETRACS ETNs) with the Securities and Exchange Commission (the “SEC”) for
the offering to which this communication relates. Before you invest, you
should read these documents and any other documents that UBS has filed
with the SEC for more complete information about UBS and the offering to
which this communication relates. You may get these documents for free
by visiting EDGAR on the SEC website at www.sec.gov.
Alternatively, you can request the applicable prospectus supplement, or
product supplement and pricing supplement, by calling toll-free
(+1-877-387 2275). In the US, securities underwriting, trading and
brokerage activities and M&A advisor activities are provided by UBS
Securities LLC, a registered broker/dealer that is a wholly owned
subsidiary of UBS AG, a member of the New York Stock Exchange and other
principal exchanges, and a member of SIPC. UBS Financial Services Inc.
is a registered broker/dealer and affiliate of UBS Securities LLC.

UBS specifically prohibits the redistribution or reproduction of this
communication in whole or in part without the prior written permission
of UBS and UBS accepts no liability whatsoever for the actions of third
parties in this respect.

Alerian MLP Index, Alerian MLP Infrastructure Index, Alerian Natural Gas
MLP Index, AMZ, AMZI, and ANGI are trademarks of Alerian and their use
is granted under a license from Alerian.

© UBS 2019. The key symbol, UBS and ETRACS are among the registered and
unregistered trademarks of UBS. Other marks may be trademarks of their
respective owners. All rights reserved.

Contacts

Media
Erica Chase
1-212-713-1302
[email protected]

Investors
+1-877-387-2275

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

For the last half century, thousands of communications professionals have turned to us to deliver their news to the audiences most important to their business through the sources they trust most. Over that time, we've gone from a single office with one full time employee to more than 500 employees in 32 bureaus.